Skip to content

Serotonin research published in 2017

43 studies whose primary subject is serotonin were published in 2017, down from 46 in 2016. Newest first. Back to the serotonin overview

Studies

Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine

The International Journal of Neuropsychopharmacology December 22, 2017 K. Fukumoto, M. Iijima, Takeo Funakoshi et al.

Abstract Background We previously reported that serotonergic transmission plays an important role in antidepressant effects of ketamine. However, detailed mechanisms have not been elucidated. Among the serotonin receptor subtypes, the serotonin1A receptor in the medial prefrontal cortex has an important role in depression. Here, we investigated the role of the medial prefrontal cortex...

Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems

European Journal of Pharmacology December 8, 2017 Dino Luethi, Marius C. Hoener, Matthias E. Liechti 41 citations

Diclofensine, diphenidine, and methoxphenidine are new psychoactive substances (NPSs) that recently appeared on the illicit drug market. Pharmacological profiling of such newly emerged drugs is crucial for a better understanding of their psychotropic effects and toxicity. We therefore investigated the potential of these NPSs to inhibit the norepinephrine, dopamine, and serotonin transporters in...

DOI: 10.1016/j.ejphar.2017.12.012 (opens in new tab) Monoaminergic Monoamine neurotransmitter Pharmacology Norepinephrine transporter +5

Serotonin 5-HT 1A receptor binding and self-transcendence in healthy control subjects - a replication study using Bayesian hypothesis testing

bioRxiv November 30, 2017 Gina Griffioen, Granville James Matheson, Simon Cervenka et al. preprint

Objective: A putative relationship between markers for the serotonin system and the personality scale self-transcendence (ST) and its subscale spiritual acceptance (SA) has been demonstrated in a previous PET study of 5-HT 1A receptor binding in healthy control subjects. The results could however not be replicated in a subsequent PET study at an independent centre. In this study, we performed a...

Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication

Psychopharmacology November 16, 2017 Eline Haijen, Magı́ Farré, Rafael de la Torre et al. 9 citations

Preclinical data have suggested involvement of the endocannabinoid (eCB) system in MDMA-induced memory impairment. Clinical research has shown that blockade of the 5-HT 2 receptor nulls memory impairment during MDMA intoxication. Interestingly, studies have demonstrated that the eCB and the 5-HT system interact. It was hypothesized that MDMA would cause an increase in eCB concentrations...

Serotonin 2A receptor disulfide bridge integrity is crucial for ligand binding to different signalling states but not for its homodimerization.

European Journal of Pharmacology November 15, 2017 Alba Iglesias, Marta Cimadevila, Rocío Ailim de La Fuente et al.

The serotonin 2A (5-HT2A) receptor is a G-protein coupled receptor (GPCR) with a conserved disulfide bridge formed by Cys148 (transmembrane helix 3, TM3) and Cys227 (extracellular loop 2, ECL-2). We hypothesized that disulfide bridges may determine serotonin 5-HT2A receptor functions such as receptor activation, functional selectivity and ligand recognition. We used the reducing agent...

DOI: 10.1016/j.ejphar.2017.09.011 (opens in new tab) Full text (opens in new tab) Clozapine pubchem cid Dl-1,4-dithiothreitol pubchem cid Disulfide bridges Phospholipase a2 +4

LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation

Frontiers in Pharmacology November 8, 2017 Rainer Kraehenmann, Dan Pokorný, Helena Aicher et al. 115 citations

Rationale: Stimulation of serotonin 2A (5-HT2A) receptors by lysergic acid diethylamide (LSD) and related compounds such as psilocybin has previously been shown to increase primary process thinking – an ontologically and evolutionary early, implicit, associative, and automatic mode of thinking which is typically occurring during altered states of consciousness such as dreaming. However, it is...

Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage.

Neurotoxicity Research November 2017 Giulia Costa, Micaela Morelli, Nicola Simola

The amphetamine-related drug 3,4-methylenedioxymethamphetamine (MDMA) is known to induce neurotoxic damage in dopaminergic regions of the mouse brain. In order to characterize how the number of administrations influenced the severity of MDMA-induced dopaminergic damage and to describe the localization and persistence of this damage, we evaluated the changes in tyrosine hydroxylase (TH) and...

DOI: 10.1007/s12640-017-9761-6 (opens in new tab) Full text (opens in new tab) Amphetamine-related drugs Dopamine transporter Glutamic acid decarboxylase-67 Noradrenaline transporter +2

Methoxetamine produces rapid and sustained antidepressant effects probably via glutamatergic and serotonergic mechanisms

Neuropharmacology November 1, 2017 Chrislean Jun Botanas, June Bryan De la Peña, Raly James Perez Custodio et al.

Depression afflicts around 16% of the world's population, making it one of the leading causes of disease burden worldwide. Despite a number of antidepressants available today, the delayed onset time and low remission rate of these treatments are still a major challenge. The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine has shown to produce rapid and sustained antidepressant effects...

Fluorinated phenmetrazine “legal highs” act as substrates for high-affinity monoamine transporters of the SLC6 family

Neuropharmacology October 12, 2017 Felix P. Mayer, Nadine V. Burchardt, Ann M Decker et al. 30 citations

A variety of new psychoactive substances (NPS) are appearing in recreational drug markets worldwide. NPS are compounds that target various receptors and transporters in the central nervous system to achieve their psychoactive effects. Chemical modifications of existing drugs can generate NPS that are not controlled by current legislation, thereby providing legal alternatives to controlled...

DOI: 10.1016/j.neuropharm.2017.10.006 (opens in new tab) Serotonin Monoamine neurotransmitter Pharmacology Amphetamine +6

Agonist E-6837 and antagonist SB-271046 of 5-HT6 receptors both reverse the depressive-like effect induced in mice by subchronic ketamine administration

Behavioural Pharmacology October 1, 2017 José E. Suárez-Santiago, Alfredo Briones-Aranda, Judith Espinosa-Raya et al.

Major depression is one of the most common affective disorders caused by schizophrenia. The administration of N-methyl-d-aspartate receptor antagonists, such as ketamine, can reproduce the negative and affective symptoms of this disorder in animals. Preclinical studies have shown that 5-HT6 receptor (5-HT6R) agonists and antagonists have a considerable antipsychotic response. The aim of the...

Dopaminergic and Serotonergic Genotypes and the Subjective Experiences of Hypnosis.

International Journal of Clinical and Experimental Hypnosis October 1, 2017 E R Katonai, Anna Szekely, A Vereczkei et al.

Hypnotizability is related to the Val158Met polymorphism of the COMT gene. The authors' aim was to find associations between candidate genes and subjective dimensions of hypnosis; 136 subjects participated in hypnosis and noninvasive DNA sampling. The phenomenological dimensions were tapped by the Archaic Involvement Measure (AIM), the Phenomenology of Consciousness Inventory (PCI), and the...

DOI: 10.1080/00207144.2017.1348848 (opens in new tab) Full text (opens in new tab) Humans Catechol o-methyltransferase Hypnosis Psychological tests +6

Serotonin 2A Receptor Signaling Underlies LSD-induced Alteration of the Neural Response to Dynamic Changes in Music

Cerebral Cortex September 12, 2017 Frederick S. Barrett, Katrin H. Preller, Marcus Herdener et al. 52 citations

Abstract Classic psychedelic drugs (serotonin 2A, or 5HT2A, receptor agonists) have notable effects on music listening. In the current report, blood oxygen level-dependent (BOLD) signal was collected during music listening in 25 healthy adults after administration of placebo, lysergic acid diethylamide (LSD), and LSD pretreated with the 5HT2A antagonist ketanserin, to investigate the role of...

3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner

Neuropsychopharmacology September 1, 2017 Elizabeth G Pitts, Adelaide R. Minerva, Erika B Chandler et al. 20 citations

3,4-Methylenedioxymethamphetamine (MDMA) increases sociality in humans and animals. Release of serotonin (5-HT) is thought to have an important role in the increase in social behaviors, but the mechanisms underlying these effects are poorly understood. Despite the advantages of nonhuman primate models, no studies have examined the mechanisms of the social effects of MDMA in nonhuman primates....

Serotonin and brain function: a tale of two receptors.

Journal of Psychopharmacology August 31, 2017 R L Carhart-Harris, D J Nutt

Previous attempts to identify a unified theory of brain serotonin function have largely failed to achieve consensus. In this present synthesis, we integrate previous perspectives with new and older data to create a novel bipartite model centred on the view that serotonin neurotransmission enhances two distinct adaptive responses to adversity, mediated in large part by its two most prevalent and...

The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish

Frontiers in Psychiatry August 13, 2017 Luisa Ponzoni, Daniela Braida, Gianpietro Bondiolotti et al. 9 citations

3,4-methylenedioxymethamphetamine (MDMA) and its derivatives, 2,5-dimethoxy-4-bromo-amphetamine hydrobromide (DOB) and para-methoxyamphetamine (PMA) are recreational drugs whose pharmacological effects have recently been attributed to serotonin 5HT2A/C receptors. However, there is growing evidence that the oxytocin/vasopressin system can modulate some the effects of MDMA. In this study, MDMA...

Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA)

Psychopharmacology July 24, 2017 Matthew B Young, Seth D. Norrholm, Lara M. Khoury et al. 103 citations

We validate enhancement of fear memory extinction by MDMA in a translational behavioral model, and reveal the importance of 5-HTT and 5-HT2A receptors to this effect. These observations support future clinical research of MDMA as an adjunct to exposure therapy, and provide important pharmacological considerations for clinical use in a population frequently treated with 5-HTT inhibitors.

DOI: 10.1007/s00213-017-4684-8 (opens in new tab) Full text (opens in new tab) MDMA Serotonin transporter Extinction optical mineralogy Pharmacology +2

MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor

Psychopharmacology July 22, 2017 Kim P. C. Kuypers, Rafael de la Torre, Magı́ Farré et al. 24 citations

MDMA has been shown to induce feelings of sociability, a positive emotional bias and enhanced empathy. While previous research has used only visual emotional stimuli, communication entails more than that single dimension and it is known that auditory information is also crucial in this process. In addition, it is, however, unclear what the neurobiological mechanism underlying these MDMA effects...

Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow

Neuroimage July 12, 2017 Candace R. Lewis, Katrin H. Preller, Rainer Kraehenmann et al. 105 citations

Psilocybin, the active compound in psychedelic mushrooms, is an agonist of various serotonin receptors. Seminal psilocybin positron emission tomography (PET) research suggested regional increases in glucose metabolism in frontal cortex (hyperfrontality). However, a recent arterial spin labeling (ASL) study suggests psilocybin may lead to hypo-perfusion in various brain regions. In this...

DOI: 10.1016/j.neuroimage.2017.07.020 (opens in new tab) Psilocybin Insula Cerebral blood flow Anterior cingulate cortex +5

MDMA-Induced Dissociative State not Mediated by the 5-HT2A Receptor

Frontiers in Pharmacology July 11, 2017 Drew J. Puxty, Johannes G. Ramaekers, Rafael de la Torre et al. 33 citations

Previous research has shown that a single dose of MDMA induce a dissociative state, by elevating feelings of depersonalization and derealization. Typically, it is assumed that action on the 5-HT2A receptor is the mechanism underlying these psychedelic experiences. In addition, other studies have shown associations between dissociative states and biological parameters (heart rate, cortisol),...

DOI: 10.3389/fphar.2017.00455 (opens in new tab) MDMA Dissociative Pharmacology Hallucinogen +1

Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation

Psychopharmacology July 1, 2017 Rainer Kraehenmann, Dan Pokorný, Leonie Vollenweider et al.

Rationale Accumulating evidence indicates that the mixed serotonin and dopamine receptor agonist lysergic acid diethylamide (LSD) induces an altered state of consciousness that resembles dreaming. Objectives This study aimed to test the hypotheses that LSD produces dreamlike waking imagery and that this imagery depends on 5-HT2A receptor activation and is related to subjective drug effects....